Aera Therapeutics
Cambridge, United States· Est.
Aera Therapeutics develops delivery platforms for genetic medicines using novel protein nanoparticle technology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $193M
About
Aera Therapeutics develops delivery platforms for genetic medicines using novel protein nanoparticle technology.
Gene TherapyDrug DeliverySynthetic Biology
Funding History
1Total raised:$193M
Series A$193M